Back
Staar Surgical 10K Form
Sell
42
STAA
Staar Surgical
Last Price:
29.02
Seasonality Move:
4.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | STAA/Staar Surgical Quarterly |
2023-11-06 | 10Q | STAA/Staar Surgical Quarterly |
2023-08-02 | 10Q | STAA/Staar Surgical Quarterly |
2023-05-03 | 10Q | STAA/Staar Surgical Quarterly |
2022-11-02 | 10Q | STAA/Staar Surgical Quarterly |
2022-08-10 | 10Q | STAA/Staar Surgical Quarterly |
Receive STAA News And Ratings
See the #1 stock for the next 7 days that we like better than STAA
STAA Financial Statistics
Sales & Book Value
Annual Sales: | $322.42M |
---|---|
Cash Flow: | $-2.42M |
Price / Cash Flow: | 53.68 |
Annual Sales: | $8.69 |
Price / Book: | 3.29 |
Profitability
EPS (TTM): | 0.44000 |
---|---|
Net Income (TTM): | $21.78M |
Gross Margin: | $252.65M |
Return on Equity: | 5.46% |
Return on Assets: | 4.35% |
Staar Surgical Earnings Forecast
Key Staar Surgical Financial Ratios
- The Gross Profit Margin over the past 36 years for STAA is 78.36%.
- The Selling, General & Administrative Expenses for STAA have been equal to 55.88% of Gross Profit Margin.
- The Research & Development expenses have been 13.77% of Revenue.
- The Interest Expense is -5.14% of Operating Income.
- The Net Earning history of STAA is 6.62% of Total Revenues.
- Per Share Earnings over the last 36 years have been positive in 18 years.
Staar Surgical Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | STAA |
CUSIP: | 852312 |
Website: | staar.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 5.99 |
Quick Ratio: | 5.18 |
Price-to-Earnings
Trailing P/E Ratio: | 66.42 |
---|---|
Forward P/E Ratio: | 35.26 |
STAA Technical Analysis vs Fundamental Analysis
Sell
42
Staar Surgical (STAA)
is a Sell
Is Staar Surgical a Buy or a Sell?
-
Staar Surgical stock is rated a Sell
The current Staar Surgical [STAA] share price is $28.56. The Score for STAA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.